Delivery Order SPE2DB24D1007-SPE2DB25FCBMA
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,926.42 to AmerisourceBergen Drug Corp for the supply of Brilinta 90 mg tablets (quantity 60s) on August 26, 2025, with completion scheduled for August 27, 2025. This firm fixed price delivery order represents a non-set-aside award executed through open competition. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, supporting the federal government's pharmaceutical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Brilinta 90 mg tablets (60-count packages) under a firm fixed-price contract valued at $2,134.02. The order was competitively awarded without a set-aside designation and carries an ultimate completion date of July 15, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform this delivery from its corporate office location. This delivery order represents a child...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,297.86 to AmerisourceBergen Drug Corp for the supply of Brilinta 90 mg tablets (60-count packages) with a completion date of May 28, 2025. This firm fixed-price delivery order represents a non-set-aside competitive award to the Conshohocken, Pennsylvania-based pharmaceutical distributor, with performance to be executed at the vendor's corporate office location. The award is a child contract under AmerisourceBergen's...
- The Defense Logistics Agency has awarded AmerisourceBergen Drug Corp a delivery order valued at $2,234.42 for Brilinta 90 mg tablets (60-count units) with a firm fixed price contract type. The award was made on August 29, 2025, with an ultimate completion date of September 2, 2025. This non-set-aside competitive award is performed at the contractor's location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger pharmaceutical supply...
- The Defense Logistics Agency awarded a $1,664.52 delivery order to AmerisourceBergen Drug Corp for 60 tablets of Brilinta 60 mg on September 8, 2025, with completion scheduled for September 9, 2025. This contract is classified as firm fixed price with no set-aside designation, indicating it was competitively awarded. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, for the supply of Brilinta 90 mg tablets in a 60-count configuration. This competitively awarded, firm fixed-price delivery order carries a ceiling value of $10,236.96 and an ultimate completion date of September 22, 2025. The award was issued on September 19, 2025, with no set-aside designation applied. As a child contract...
- The Defense Logistics Agency awarded a delivery order valued at $4,775.51 to AmerisourceBergen Drug Corp for the supply of Brilinta 90 mg tablets (60-count units) on September 5, 2025, with completion expected by September 8, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The contract represents a child order under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $1,922.04 to AmerisourceBergen Drug Corp for the supply of Brilinta 90 mg tablets (60-count) on July 30, 2025, with completion scheduled for July 31, 2025. This firm fixed-price delivery order represents a non-competitive set-aside procurement and is being performed at the contractor's Conshohocken, Pennsylvania location. The award is issued as a child contract under AmerisourceBergen Drug Corp's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $1,248.39 to AmerisourceBergen Drug Corp for the supply of Brilinta 90 mg tablets (60-count packages). This is a firm fixed-price, competitively awarded delivery order with no set-aside designation, with an ultimate completion date of August 4, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Brilinta 60 mg tablets in quantities of 60 units, with a contract ceiling value of $1,387.10. This competitively awarded, firm fixed-price delivery order is set to be completed by September 15, 2025, and represents fulfillment under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The place of performance is located in...
- SPE2DB24D1007Indefinite Delivery Contract
- SPE2DB24D1007-SPE2DB25FCBMADelivery Order
The Defense Logistics Agency awarded a delivery order valued at $2,350.29 to AmerisourceBergen Drug Corp for the supply of Brilinta 90 mg tablets (60-count packages) on April 25, 2025, with completion scheduled for April 28, 2025. This firm fixed price delivery order represents a non-competitive award issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.99 billion global pharmaceutical support vehicle running through December 2026. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order falls within AmerisourceBergen's broader role as a primary pharmaceutical distributor for federal medical procurement, particularly serving military and veteran healthcare systems through the DLA Medical Supply Chain. The award of Brilinta, an antiplatelet medication, exemplifies the company's ongoing supply of brand-name pharmaceuticals to support Defense Health Agency operations and other federal healthcare customers. AmerisourceBergen's extensive contract portfolio with DLA demonstrates its established capability to fulfill federal medical supply requirements across multiple therapeutic domains, from specialty medications to vaccines and medical devices, reinforcing its critical position within the federal healthcare supply infrastructure.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.4k | 4/25/25 |